Skip to content

Improving perceived self-efficacy and autonomy in stroke survivors: An Interventional study

Perceived Self-Efficacy and Autonomy in Stroke Survivors: An Interventional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093373
Enrollment
72
Registered
2025-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I698- Sequelae of other cerebrovasculardiseases Health Condition 2: I699- Sequelae of unspecified cerebrovascular diseases Health Condition 3: F59- Unspecified behavioral syndromes associated with physiological disturbances and physical factors Health Condition 4: F54- Psychological and behavioral factors associated with disorders or diseases classified elsewhere Health Condition 5: I678- Other specified cerebrovascular diseases Health Condition 6: G94- Other disorders of bra

Interventions

Intervention1: Self-efficacy intervention: Behavioural Intervention based on Banduras self efficacy model. Control Intervention1: conventional therapy: conventional therapy (including physiotherapy, o

Sponsors

Sharda University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Persons with stroke within 2 years of the event. They should be willing to participate in the study. Score more than 24 in MMSE/MOCA

Exclusion criteria

Exclusion criteria: 1) Medically unstable 2) Persons with stroke after 2 years of onset 3) With cognitive impairment, clinical depression, aphasia, or other co-morbidities.

Design outcomes

Primary

MeasureTime frame
1) change in perceived self efficacy in stroke survivors as measured by SSEQ ( stroke self efficacy questionnaire). 2) changes in autonomy in stroke survivors as measured by IPAQ ( impact on participation and autonomy questionnaire in stroke survivors.Timepoint: At baseline , after intervention of 8 weeks and follow up at 12 weeks.

Secondary

MeasureTime frame
Functional status as measured by barthel indexTimepoint: Baseline, after intervention in 8 weeks and follow up at 12 weeks

Countries

India

Contacts

Public ContactGita Jyoti Ojha

Sharda University

toran.talwar@sharda.ac.in09350828430

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026